Evolent Depreciation And Amortization vs Selling General Administrative Analysis
EVH Stock | USD 22.89 0.38 1.63% |
Evolent Health financial indicator trend analysis is much more than just examining Evolent Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Evolent Health is a good investment. Please check the relationship between Evolent Health Depreciation And Amortization and its Selling General Administrative accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.
Depreciation And Amortization vs Selling General Administrative
Depreciation And Amortization vs Selling General Administrative Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Evolent Health Depreciation And Amortization account and Selling General Administrative. At this time, the significance of the direction appears to have strong relationship.
The correlation between Evolent Health's Depreciation And Amortization and Selling General Administrative is 0.77. Overlapping area represents the amount of variation of Depreciation And Amortization that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of Evolent Health, assuming nothing else is changed. The correlation between historical values of Evolent Health's Depreciation And Amortization and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation And Amortization of Evolent Health are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Depreciation And Amortization i.e., Evolent Health's Depreciation And Amortization and Selling General Administrative go up and down completely randomly.
Correlation Coefficient | 0.77 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Selling General Administrative
Most indicators from Evolent Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Evolent Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.As of now, Evolent Health's Enterprise Value Multiple is increasing as compared to previous years.
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 908.0M | 1.4B | 2.0B | 2.1B | Depreciation And Amortization | 60.0M | 67.2M | 123.4M | 129.6M |
Evolent Health fundamental ratios Correlations
Click cells to compare fundamentals
Evolent Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Evolent Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.5B | 1.4B | 1.4B | 1.8B | 2.7B | 2.8B | |
Other Current Liab | 129.2M | 321.5M | 330.4M | 363.4M | 610.3M | 640.8M | |
Total Current Liabilities | 192.8M | 401.8M | 445.5M | 433.4M | 674.2M | 708.0M | |
Total Stockholder Equity | 922.4M | 619.6M | 693.6M | 859.4M | 1.1B | 706.1M | |
Property Plant And Equipment Net | 157.3M | 144.0M | 131.6M | 136.9M | 90.2M | 84.7M | |
Net Debt | 267.8M | 19.3M | 14.2M | 287.9M | 452.0M | 474.6M | |
Retained Earnings | (252.0M) | (589.2M) | (626.8M) | (606.2M) | (719.2M) | (683.2M) | |
Accounts Payable | 37.5M | 32.1M | 96.1M | 57.2M | 48.2M | 48.9M | |
Cash | 101.0M | 340.5M | 266.3M | 188.2M | 192.8M | 176.4M | |
Non Current Assets Total | 1.3B | 824.1M | 895.5M | 1.3B | 2.0B | 2.1B | |
Non Currrent Assets Other | 8.3M | 7.3M | 13.0M | 32.3M | 20.9M | 21.9M | |
Other Assets | 92.0M | 186.5M | 52.4M | 32.3M | 33.0M | 60.4M | |
Cash And Short Term Investments | 101.0M | 340.5M | 266.3M | 188.2M | 192.8M | 196.3M | |
Net Receivables | 77.4M | 126.3M | 130.6M | 254.7M | 446.7M | 469.1M | |
Common Stock Shares Outstanding | 82.4M | 84.9M | 86.1M | 93.7M | 111.3M | 70.4M | |
Liabilities And Stockholders Equity | 1.5B | 1.4B | 1.4B | 1.8B | 2.7B | 2.8B | |
Other Current Assets | 200.5M | 524.4M | 435.3M | 451.1M | 30.3M | 28.8M | |
Other Stockholder Equity | 1.2B | 1.2B | 1.3B | 1.5B | 1.6B | 1.7B | |
Total Liab | 569.0M | 750.6M | 725.8M | 957.9M | 1.6B | 1.7B | |
Total Current Assets | 228.8M | 546.1M | 524.0M | 478.1M | 683.7M | 354.3M | |
Intangible Assets | 308.5M | 268.1M | 279.8M | 442.8M | 752.0M | 789.6M | |
Other Liab | 13.7M | 455.2M | 6.9M | 55.4M | 63.8M | 71.7M | |
Current Deferred Revenue | 19.8M | 14.3M | 11.9M | 5.8M | 6.0M | 5.7M | |
Short Term Investments | 1.8M | 3.9M | 75.7M | 14.5M | 13.8M | 25.7M | |
Non Current Liabilities Total | 376.2M | 348.8M | 280.3M | 524.4M | 938.4M | 985.3M | |
Inventory | 78.5M | (150.1M) | (445.1M) | (308.2M) | (415.9M) | 1.05 | |
Property Plant And Equipment Gross | 157.3M | 144.0M | 250.7M | 287.4M | 248.7M | 139.8M | |
Accumulated Other Comprehensive Income | (234K) | (278K) | (362K) | (1.2M) | (1.3M) | (1.3M) | |
Short Term Debt | 6.3M | 33.9M | 7.1M | 7.1M | 9.7M | 9.3M | |
Property Plant Equipment | 85.2M | 86.2M | 81.4M | 87.9M | 101.1M | 60.1M | |
Net Tangible Assets | 41.8M | (3.2M) | (12.4M) | (306.1M) | (275.5M) | (261.8M) | |
Long Term Debt | 293.7M | 263.3M | 215.7M | 413.0M | 597.0M | 626.9M | |
Good Will | 572.1M | 354.7M | 426.3M | 722.8M | 1.1B | 707.6M | |
Common Stock Total Equity | 846K | 859K | 908K | 1.0M | 1.2M | 791.4K | |
Deferred Long Term Liab | 1.9M | 728K | 1.4M | 4.7M | 4.3M | 4.1M | |
Long Term Investments | 139.4M | 17.4M | 5.5M | 4.5M | 4.9M | 4.7M | |
Common Stock | 846K | 859K | 908K | 1.0M | 1.2M | 839.2K | |
Retained Earnings Total Equity | (252.0M) | (589.2M) | (626.8M) | (606.2M) | (545.5M) | (518.3M) |
Currently Active Assets on Macroaxis
MSFT | Microsoft | |
GM | General Motors | |
CRM | Salesforce | |
MSFT | Microsoft | |
GOOG | Alphabet Inc Class C |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Evolent Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.26) | Revenue Per Share 19.283 | Quarterly Revenue Growth 0.496 | Return On Assets 0.0062 | Return On Equity (0.09) |
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.